Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials

(2015) P. Genereux et al.   Circulation-Cardiovascular Interventions

Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials

(2015) Salvatore Cassese et al.   Clinical Research in Cardiology

Cangrelor: A Review in Percutaneous Coronary Intervention

(2015) Gillian M. Keating   DRUGS

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

(2015) Fumiyuki Otsuka et al.   EUROPEAN HEART JOURNAL

Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary

(2015) Robert A. Byrne et al.   EUROPEAN HEART JOURNAL

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

(2015) S. Schulz-Schupke et al.   EUROPEAN HEART JOURNAL

Bioresorbable Drug-Eluting Stents

(2015) Robert A. Byrne et al.   JACC-Cardiovascular Interventions

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

(2015) Robert W. Yeh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

(2015) Martine Gilard et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation

(2015) Katrin A. Fiedler et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

(2015) Bent Raungaard et al.   LANCET

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

(2015) Patrick W Serruys et al.   LANCET

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

(2015) Davide Capodanno et al.   EuroIntervention

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

(2015) Robin P. Kraak et al.   EuroIntervention

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

(2015) Davide Capodanno et al.   EuroIntervention

Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut to Wall Detachment Distance

(2014) Nicolas Foin et al.   Circulation-Cardiovascular Interventions

Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios

(2014) Milosz Jaguszewski et al.   Clinical Research in Cardiology

Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting

(2014) Salvatore Cassese et al.   EUROPEAN HEART JOURNAL

Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation

(2014) S. Silber et al.   EUROPEAN HEART JOURNAL

Pharmacological inhibition of coronary restenosis: systemic and local approaches

(2014) Elena Guerra et al.   EXPERT OPINION ON PHARMACOTHERAPY

Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease

(2014) Jens Wiebe et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy

(2014) Antonio Colombo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition

(2014) Guilherme F. Attizzani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Current Treatment of In-Stent Restenosis

(2014) Fernando Alfonso et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial

(2014) Jean-Philippe Collet et al.   LANCET

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

(2014) Laura Mauri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation

(2014) K. Anette Fiedler et al.   THROMBOSIS AND HAEMOSTASIS

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis

(2014) S. Windecker et al.   BMJ-British Medical Journal

Tissue Characterization After Drug-Eluting Stent Implantation Using Optical Coherence Tomography

(2013) Caroline Malle et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

(2013) Fumiyuki Otsuka et al.   CIRCULATION

Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

(2013) Cheol Whan Lee et al.   CIRCULATION

The promises of PCSK9 inhibition

(2013) Francine Petrides et al.   CURRENT OPINION IN LIPIDOLOGY

Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics

(2013) Masataka Nakano et al.   EUROPEAN HEART JOURNAL

Coronary stents: novel developments

(2013) Giulio G Stefanini et al.   HEART

Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography

(2013) Salvatore Cassese et al.   HEART

Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents

(2013) Tomohisa Tada et al.   JACC-Cardiovascular Interventions

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

(2013) Gregg W Stone et al.   LANCET

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

(2013) Roxana Mehran et al.   LANCET

Drug-coated balloon therapy in coronary and peripheral artery disease

(2013) Robert A. Byrne et al.   Nature Reviews Cardiology

OCT Analysis in Patients With Very Late Stent Thrombosis

(2013) Soo-Jin Kang et al.   JACC-Cardiovascular Imaging

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

(2012) Marco Valgimigli et al.   CIRCULATION

Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents

(2012) Lorenz Räber et al.   CIRCULATION

Predictors for Neoatherosclerosis

(2012) Taishi Yonetsu et al.   Circulation-Cardiovascular Imaging

Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study

(2012) M. Charlot et al.   EUROPEAN HEART JOURNAL

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials

(2012) Salvatore Cassese et al.   EUROPEAN HEART JOURNAL

Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent Thrombosis

(2012) Ehrin J. Armstrong et al.   JACC-Cardiovascular Interventions

A New Strategy for Discontinuation of Dual Antiplatelet Therapy

(2012) Byeong-Keuk Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents

(2012) Dietmar Trenk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

(2012) Manel Sabate et al.   LANCET

Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting

(2012) Jean-Philippe Collet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug–Eluting Stent Implantation

(2011) Soo-Jin Kang et al.   CIRCULATION

Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents

(2011) Lorenz Räber et al.   CIRCULATION

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

(2011) Hyeon-Cheol Gwon et al.   CIRCULATION

No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting

(2011) D. Sibbing et al.   EUROPEAN HEART JOURNAL

Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

(2011) Matthew J. Price   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis

(2011) Guillaume Cayla et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Pathology of Neoatherosclerosis in Human Coronary Implants

(2011) Gaku Nakazawa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Prospective Natural-History Study of Coronary Atherosclerosis

(2011) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients

(2011) Sudhir Rathore et al.   EuroIntervention

Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents

(2010) Takeshi Kimura et al.   CIRCULATION

Very Long-Term (15 to 20 Years) Clinical and Angiographic Outcome After Coronary Bare Metal Stent Implantation

(2010) Kyohei Yamaji et al.   Circulation-Cardiovascular Interventions

Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

(2010) Jessica L. Mega et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Double-Blind, Randomized Study on Prevention and Existence of a Rebound Phenomenon of Platelets After Cessation of Clopidogrel Treatment

(2010) Dirk Sibbing et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Optical coherence tomography patterns of stent restenosis

(2009) Nieves Gonzalo et al.   AMERICAN HEART JOURNAL

C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation

(2009) Duk-Woo Park et al.   CIRCULATION

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

(2009) D. Sibbing et al.   EUROPEAN HEART JOURNAL

Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period

(2009) S. Schulz et al.   EUROPEAN HEART JOURNAL

Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer

(2009) Robert A. Byrne et al.   JACC-Cardiovascular Interventions

Predictors of Coronary Stent Thrombosis

(2009) Jochem W. van Werkum et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis

(2009) Dirk Sibbing et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

One Step Forward and Two Steps Back With Drug-Eluting-Stents

(2009) Gaku Nakazawa et al.   JACC-Cardiovascular Imaging

Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials

(2008) R Iijima et al.   HEART